Torricelli Robert G reported grant involving 12,481 shares of CLOVER HEALTH INVESTMENTS, CORP. DE at $0.00 for $0 on Sep 30, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Oct 2, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
12,481Class A Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
186,897Direct
Trade date
Sep 30, 2026Grant
Filed
Oct 2, 2026, 4:14 PM ET2-day reporting delay
Accession
0001801170-26-000243Code A · Transaction 234558
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

CLOV price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CLOV · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −5.3%1w ago +4.3%1d ago −1.1%
Returns since7d +9.4%30d +1.8%90d180d1y

Footnotes in full

F1: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs") granted to the Reporting Person on September 30, 2026. The RSUs will vest in full on the first anniversary of September 30, 2026 subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.